Serum Biomarkers Indicate Long-term Reduction in Liver Fibrosis in Patients With Sustained Virological Response to Treatment for HCV Infection (Q40068050)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Serum Biomarkers Indicate Long-term Reduction in Liver Fibrosis in Patients With Sustained Virological Response to Treatment for HCV Infection	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

Serum Biomarkers Indicate Long-term Reduction in Liver Fibrosis in Patients With Sustained Virological Response to Treatment for HCV Infection (English)

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

0 references

0 references

Anne C. Moorman

object named as

Anne C Moorman

7

0 references

Scott D Holmberg

6

object named as

Scott D Holmberg

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

author name string

Mei Lu

1

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

Jia Li

2

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

Talan Zhang

3

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

Loralee B Rupp

4

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

Sheri Trudeau

5

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

Philip R Spradling

8

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

Eyasu H Teshale

9

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

Fujie Xu

10

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

Joseph A Boscarino

11

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

Mark A Schmidt

12

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

Vinutha Vijayadeva

13

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

Stuart C Gordon

14

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

Chronic Hepatitis Cohort Study Investigators

15

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

language of work or name

0 references

publication date

21 January 2016

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

Clinical Gastroenterology and Hepatology

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

14

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

7

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

1044-1055.e3

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

A comparison of alternative strategies for choosing control populations in observational studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5726250

15 June 2018

Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5726250

15 June 2018

Successful treatment with telaprevir-based regimens for chronic hepatitis C results in significant improvements to serum markers of liver fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5726250

15 June 2018

Liver fibrosis progression in hepatitis C virus infection after seroconversion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5726250

15 June 2018

Comparative effectiveness research of chronic hepatitis B and C cohort study (CHeCS): improving data collection and cohort identification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5726250

15 June 2018

The validity of serum markers for fibrosis staging in chronic hepatitis B and C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5726250

15 June 2018

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5726250

15 June 2018

An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5726250

15 June 2018

Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5726250

15 June 2018

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5726250

15 June 2018

Hepatitis C treatment and SVR: the gap between clinical trials and real-world treatment aspirations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5726250

17 June 2018

Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5726250

20 August 2018

Noninvasive estimation of fibrosis progression overtime using the FIB-4 index in chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5726250

20 August 2018

A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5726250

20 August 2018

Histologic outcomes in hepatitis C-infected patients with varying degrees of virologic response to interferon-based treatments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5726250

20 August 2018

Reversibility of hepatitis C virus-related cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5726250

20 August 2018

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5726250

20 August 2018

Baseline Characteristics and Mortality Among People in Care for Chronic Viral Hepatitis: The Chronic Hepatitis Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5726250

2 December 2018

Beyond subgroup analysis: improving the clinical interpretation of treatment effects in stroke research

1 reference

https://pubmed.ncbi.nlm.nih.gov/26804385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/26804385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26804385

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.CGH.2016.01.009

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

1 reference

Europe PubMed Central

10 January 2018

http://europepmc.org/abstract/PMC/5726250

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40068050&oldid=1883582874"